Company profile: Nucleai
1.1 - Company Overview
Company description
- Provider of an AI-powered spatial biology platform designed to enhance drug development and improve patient outcomes.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nucleai
Tx3
HQ: United States
Website
- Description: Provider of automated quality and compliance SaaS solutions for software testing within Life Science companies, enabling agile adoption and efficient adherence to regulatory requirements such as 21 CFR Part 11. Offerings include Tricentis Tosca, qTest, NeoLoad, LiveCompare, and Data Integrity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tx3 company profile →
OMNY Health
HQ: United States
Website
- Description: Provider of a healthcare data sharing and research platform connecting providers and life sciences to improve patient care and drive innovation; real-world data solutions with comprehensive patient data; operational and clinical decision-making tools; custom data and dashboards; medical device insights; and social determinants of health datasets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OMNY Health company profile →
Triomics
HQ: United States
Website
- Description: Provider of an oncology-focused generative AI platform for clinical trial matching. Offers OncoLLM to process clinical and genomic data; Prism for EHR-integrated trial matching; Harmony for EHR data curation for tumor registries and precision oncology; Symphony to streamline care via triage, identifying missing data, and pre-charting; and Clinical Navigators for clinical workflow integration, trial navigation, and registry engagement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Triomics company profile →
Gene Logic
HQ: United States
Website
- Description: Provider of comprehensive Genomic Reference Databases and GLP-compliant Microarray Services as part of an integrated genomics offering, serving over two-thirds of the top 25 pharma companies, leading research institutes, and emerging biotech companies worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gene Logic company profile →
Within3
HQ: United States
Website
- Description: Provider of a SaaS virtual engagement and digital collaboration platform for life science companies to compliantly connect and engage physicians, nurses, payers, and patients in groups large or small; offerings include an Insights Management Platform, AI-powered virtual engagement applications for global stakeholder discussions, client success support, and data science services for disease community analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Within3 company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nucleai
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nucleai
2.2 - Growth funds investing in similar companies to Nucleai
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nucleai
4.2 - Public trading comparable groups for Nucleai
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →